Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BY-NC-NDChemistry & biodiversity

Synthesis of 1,2,3-Triazole Derivatives of N,N-Dimethyltryptamine Isolated From Mimosa tenuiflora Root Bark: Antiplasmodial Activity In Silico and In Vitro.

2 more authors
5 affiliations
  1. 1Department of Chemistry, Federal University of Piauí, Teresina, Brazil.
  2. 2Department of Chemistry, Federal University of Espírito Santo, Vitória, Brazil.
  3. 3Research Center in Biological Chemistry (NQBio), Federal University of São João Del-Rei, Divinópolis, Brazil.
  4. 4Immunopathology and Tropical Diseases Laboratory, Federal Research and Educational Support Center in Health (NUPADS), Institute of Health Sciences, University of Mato Grosso, Sinop, Brazil.
  5. 5Department of Biotechnology, SGB Amravati University, Amravati, Maharashtra, India.

Abstract

Malaria is a severe parasitic disease, with Plasmodium falciparum as one of the main etiological agents. The growing resistance to antimalarial drugs underscores the urgent need for the development of new therapeutic agents. This study describes the semisynthesis of eight new 1,4-disubstituted 1,2,3-triazole derivatives (3-10) from N,N-dimethyltryptamine (1), isolated from Mimosa tenuiflora. The derivatives were obtained through copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) reactions and characterized by NMR and mass spectrometry. Compound 1 showed low in vitro activity against the W2 strain of P. falciparum (IC₅₀ = 288.4 ± 28.53 µM), whereas compound 4 demonstrated promising activity (IC₅₀ = 4.8 ± 0.32 µM), with higher selectivity toward the TOV-21G cell line. In in silico studies, all derivatives showed more favorable binding energy values compared to compound 1, particularly compound 7 (-9.8 kcal/mol) relative to the crystallographic ligand (-6.9 kcal/mol). These results highlight the importance of structural modifications in the development of new antimalarial agents.

Related

  1. Targeting FTSJ1 to Restore TP53 Function in Nonsense Mutation-Driven Cancer: Computational and Experimental Evaluation of 1,2,4-Triazole Derivatives
    Muhammad Sohaib Roomi, Giulia Culletta, Vincenzo Lombardo +8
    MoleculesPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  2. Synthesis and radioligand binding studies of bis-(8-isopropyl-isoquinolinium) derivatives as ligands for apamin-sensitive sites on cloned SK2 and SK3 channels
    Eduard Badarau, Sébastien Dilly, Fabien Dufour +3
    Bioorganic and Medicinal Chemistry LettersPeer-reviewedLicence not stated6 citedMolecular biology & gene regulationHAL
  3. Fragment‐Linked Purine Derivatives as Inhibitors of (p)ppGpp Synthetases: Design, Synthesis, and Structure‐Activity Relationships
    Rayan Aboalgasim Makawi Abdalrahman, Katharina Sophie Erlitz, Joana Massa +4
    Archiv Der PharmaziePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  4. Novel Quinoxaline-Based Cyanocarbonimidodithioate Derivatives as Non-Hydroxamate Selective HDAC8 Inhibitors: Design, Synthesis, Biological Evaluation and Mechanistic Studies
    Kosana Sai Chaitanya, Dharani Sen, Markus Schweipert +9
    ChemRxivPreprintCC BYFull textMolecular biology & gene regulationChemRxiv
  5. Design, Synthesis, Evaluation, and Molecular Dynamics Simulation of Tadalafil Derivatives for the Treatment of Erectile Dysfunction
    Wentao Liu, Bin Zhang, Yuping Jia +8
    MoleculesPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMCDOAJ
BibTeX
@article{sousa2026synthesis,
  title = {{Synthesis of 1,2,3-Triazole Derivatives of N,N-Dimethyltryptamine Isolated From Mimosa tenuiflora Root Bark: Antiplasmodial Activity In Silico and In Vitro.}},
  author = {Renato Pinto de Sousa and William Cezar de Lima Silva and Caíque Lopes Duarte and Ana Claudia de Souza Pinto and Amanda Luisa da Fonseca and Fernanda Alice de Oliveira and Fernando de Pilla Varotti and Bruno Antônio Marinho Sanchez and Mahendra Rai and Maurício Pires de Moura do Amaral and Mariana Helena Chaves and João Sammy Nery de Souza and Warley de Souza Borges and Gerardo Magela Vieira Júnior},
  journal = {Chemistry \& biodiversity},
  year = {2026},
  month = oct,
  doi = {10.1002/cbdv.71849},
  url = {https://europepmc.org/article/MED/42904838},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Synthesis of 1,2,3-Triazole Derivatives of N,N-Dimethyltryptamine Isolated From Mimosa tenuiflora Root Bark: Antiplasmodial Activity In Silico and In Vitro.
AU  - Renato Pinto de Sousa
AU  - William Cezar de Lima Silva
AU  - Caíque Lopes Duarte
AU  - Ana Claudia de Souza Pinto
AU  - Amanda Luisa da Fonseca
AU  - Fernanda Alice de Oliveira
AU  - Fernando de Pilla Varotti
AU  - Bruno Antônio Marinho Sanchez
AU  - Mahendra Rai
AU  - Maurício Pires de Moura do Amaral
AU  - Mariana Helena Chaves
AU  - João Sammy Nery de Souza
AU  - Warley de Souza Borges
AU  - Gerardo Magela Vieira Júnior
PY  - 2026
DA  - 2026/10/01
JO  - Chemistry & biodiversity
DO  - 10.1002/cbdv.71849
UR  - https://europepmc.org/article/MED/42904838
AB  - Malaria is a severe parasitic disease, with Plasmodium falciparum as one of the main etiological agents. The growing resistance to antimalarial drugs underscores the urgent need for the development of new therapeutic agents. This study describes the semisynthesis of eight new 1,4-disubstituted 1,2,3-triazole derivatives (3-10) from N,N-dimethyltryptamine (1), isolated from Mimosa tenuiflora. The derivatives were obtained through copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) reactions and characterized by NMR and mass spectrometry. Compound 1 showed low in vitro activity against the W2 strain of P. falciparum (IC₅₀ = 288.4 ± 28.53 µM), whereas compound 4 demonstrated promising activity (IC₅₀ = 4.8 ± 0.32 µM), with higher selectivity toward the TOV-21G cell line. In in silico studies, all derivatives showed more favorable binding energy values compared to compound 1, particularly compound 7 (-9.8 kcal/mol) relative to the crystallographic ligand (-6.9 kcal/mol). These results highlight the importance of structural modifications in the development of new antimalarial agents.
SN  - 1612-1872
SN  - 1612-1880
ER  -